12:27 PM EST - BioMark Diagnostics Inc : Announced today that its poster abstract has been accepted for presentation at the upcoming 70th Annual Conference of the American Society for Mass Spectrometry taking place on June 5 - 9, 2022 at the Minneapolis Convention Center in Minneapolis, Minnesota. The Company will be presenting new data on plasma metabolic biomarkers for early cancer detection arising from its collaborative research and development works performed with Quebec-based Phytronix Technologies Inc. BioMark Diagnostics Inc
shares C.BUX are trading unchanged at $0.22.
